The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The cellular basis underlying the complex clinical symptomatology of bipolar disorder and the mechanisms underlying the actions of its effective treatments have not yet been fully elucidated. This study investigated the role of hippocampal synaptic AMPA receptors. We found that chronic administration of the antimanic agents lithium and valproate (VPA) reduced synaptic AMPA receptor GluR1/2 in hippocampal neurons in vitro and in vivo. Electrophysiological studies confirmed that the AMPA/NMDA ratio was reduced in CA1 regions of hippocampal slices from lithium-treated animals. Reduction in GluR1 phosphorylation at its cAMP-dependent protein kinase A site by the synthetic peptide TAT-S845, which mimics the effects of lithium or VPA, was sufficient to attenuate surface and synaptic GluR1/2 levels in hippocampal neurons in vitro and in vivo. Intrahippocampal infusion studies with the AMPA-specific inhibitor GYKI 52466 [4-(8-methyl-9 H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)-benzenamine hydrochloride], a GluR1-specific TAT-S845 peptide, showed that GluR1/2 was essential for the development of manic/hedonic-like behaviors such as amphetamine-induced hyperactivity. These studies provide novel insights into the role of hippocampal GluR1/2 receptors in mediating facets of the manic syndrome and offer avenues for the development of novel therapeutics for these disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · cited 1×
“This has led to the investigation of putative roles for intracellular signaling cascades and glutamatergically mediated synaptic plasticity in bipolar disorder (Coyle and Duman, 2003; Du et al., 2003a; Nestler and Carlezon, 2006; Young, 2007).”
BackgroundHayashi, Y., Shi, S.-H., Esteban, J. A., Piccini, A., Poncer, J.-C., & Malinow, R. (2000) · Science · doi:10.1126/science.287.5461.2262 · Cited by 1,524 · cited 4×
“…of AMPA receptors during formation of LTP have been studied extensively by elegant electrophysiological assays in hippocampal slice cultures (Hayashi et al., 2000; Zhu et al., 2000; Shi et al., 2001) and corroborated by cellular biological studies in dissociated cultures (Sheng and Lee,…”
BackgroundInfluentialThe cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182 · cited 2×
“Historically, the brain systems that have received the greatest attention in neurobiological studies of mood disorders were the monoaminergic neurotransmitter systems, which are extensively distributed throughout the network of limbic, striatal, hippocampal, and prefrontal cortical neuronal circuits and are thought to…”
BackgroundSelf-citationDrevets, W. C. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00203-8 · Cited by 1,146 · cited 2×
“Historically, the brain systems that have received the greatest attention in neurobiological studies of mood disorders were the monoaminergic neurotransmitter systems, which are extensively distributed throughout the network of limbic, striatal, hippocampal, and prefrontal cortical neuronal circuits and are thought to…”
BackgroundRegulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity
Lee, H.-K., Barbarosie, M., Kameyama, K., Bear, M. F., & Huganir, R. L. (2000) · Nature · doi:10.1038/35016089 · Cited by 1,116 · cited 3×
“…regulates the ion channel properties and synaptic trafficking of GluR1-containing AMPA receptors during hippocampal long-term potentiation (LTP) (Roche et al., 1996; Barria et al., 1997; Mammen et al., 1997; Derkach et al., 1999; Banke et al., 2000; Lee et al., 2000; Esteban et al., 2003).”
BackgroundShi, S.-H., Hayashi, Y., Esteban, J. A., & Malinow, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00321-x · Cited by 1,094
PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity
Esteban, J. A., Shi, S.-H., Wilson, C., Nuriya, M., Huganir, R. L., & Malinow, R. (2003) · Nature Neuroscience · doi:10.1038/nn997 · Cited by 894 · cited 1×
“…regulates the ion channel properties and synaptic trafficking of GluR1-containing AMPA receptors during hippocampal long-term potentiation (LTP) (Roche et al., 1996; Barria et al., 1997; Mammen et al., 1997; Derkach et al., 1999; Banke et al., 2000; Lee et al., 2000; Esteban et al., 2003).”
BackgroundEvidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons
Wenthold, R., Petralia, R., Blahos J, II, & Niedzielski, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-01982.1996 · Cited by 850 · cited 1×
“In the adult hippocampus (Loza et al., 2005; Liu et al., 2007), the AMPA receptor population comprises primarily glutamate receptor 1 (GluR1)/GluR2 and GluR2/GluR3 heteromers (Wenthold et al., 1996).”
BackgroundDerkach, V., Barria, A., & Soderling, T. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3269 · Cited by 842 · cited 1×
“…regulates the ion channel properties and synaptic trafficking of GluR1-containing AMPA receptors during hippocampal long-term potentiation (LTP) (Roche et al., 1996; Barria et al., 1997; Mammen et al., 1997; Derkach et al., 1999; Banke et al., 2000; Lee et al., 2000; Esteban et al., 2003).”
BackgroundCharacterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit
Roche, K. W., O'Brien, R. J., Mammen, A. L., Bernhardt, J., & Huganir, R. L. (1996) · Neuron · doi:10.1016/s0896-6273(00)80144-0 · Cited by 812
Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase
Banke, T. G., Bowie, D., Lee, H.-K., Huganir, R. L., Schousboe, A., & Traynelis, S. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00089.2000 · Cited by 652 · cited 2×
“…regulates the ion channel properties and synaptic trafficking of GluR1-containing AMPA receptors during hippocampal long-term potentiation (LTP) (Roche et al., 1996; Barria et al., 1997; Mammen et al., 1997; Derkach et al., 1999; Banke et al., 2000; Lee et al., 2000; Esteban et al., 2003).”
BackgroundPrien, R. F. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220086014 · Cited by 565 · cited 1×
“We found that imipramine, which can provoke mania in humans (Prien et al., 1973, 1984), significantly enhanced GluR2 at synapses in hippocampus (control: 100 11.2%, n 7; imipramine: 131.6 7.23%, n 8; Student’s t test, p 0.033) (Fig.”
BackgroundInfluentialPrien, R. F. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200030104017 · Cited by 448 · cited 1×
“We found that imipramine, which can provoke mania in humans (Prien et al., 1973, 1984), significantly enhanced GluR2 at synapses in hippocampus (control: 100 11.2%, n 7; imipramine: 131.6 7.23%, n 8; Student’s t test, p 0.033) (Fig.”
BackgroundInfluentialMammen, A. L., Kameyama, K., Roche, K. W., & Huganir, R. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32528 · Cited by 441
Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity
Zhu, J. J., Esteban, J. A., Hayashi, Y., & Malinow, R. (2000) · Nature Neuroscience · doi:10.1038/80614 · Cited by 437 · cited 2×
“…during formation of LTP have been studied extensively by elegant electrophysiological assays in hippocampal slice cultures (Hayashi et al., 2000; Zhu et al., 2000; Shi et al., 2001) and corroborated by cellular biological studies in dissociated cultures (Sheng and Lee, 2001; Passafaro et al.,…”
BackgroundDu, J., Feng, L., Yang, F., & Lu, B. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.6.1423 · Cited by 178
Self-citationDu, J., Gray, N. A., Falke, C. A., Chen, W., Yuan, P., Szabo, S. T., Einat, H., & Manji, H. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1258-04.2004 · Cited by 157 · cited 11×
“Our previous work had established that synaptic NR1 levels do not change after lithium treatment in vivo (Du et al., 2004).”
BackgroundResultInfluentialSelf-citation
Cited by
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Self-citationKim, Y.-K., Na, K.-S., Myint, A.-M., & Leonard, B. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.008 · Cited by 620
Dynamic regulation of mitochondrial function by glucocorticoids
Du, J., Wang, Y., Hunter, R., Wei, Y., Blumenthal, R., Falke, C., Khairova, R., Zhou, R., Yuan, P., Machado-Vieira, R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812671106 · Cited by 494
Self-citationValproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
Romoli, M., Mazzocchetti, P., D'Alonzo, R., Siliquini, S., Rinaldi, V. E., Verrotti, A., Calabresi, P., & Costa, C. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666181227165722 · Cited by 372
Khairova, R. A., Machado-Vieira, R., Du, J., & Manji, H. K. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709009924 · Cited by 350
Self-citation
Metadata
- Authors
- Du, J., Creson, T. K., Wu, L.-J., Ren, M., Gray, N. A., Falke, C., Wei, Y., Wang, Y., Blumenthal, R., Machado-Vieira, R., Yuan, P., Chen, G., Zhuo, M., & Manji, H. K.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-01-02
- Volume
- 28
- Issue
- 1
- Pages
- 68-79
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2094730014
- Cited by
- 107
- References
- 19
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.